{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699993551785472.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1023/b:thro.0000011377.78585.63"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1023/B:THRO.0000011377.78585.63.pdf"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/article/10.1023/B:THRO.0000011377.78585.63/fulltext.html"}}],"dc:title":[{"@value":"Quality Assessment of Anticoagulation Dose Management: Comparative Evaluation of Measures of Time-in-Therapeutic Range"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699993551785472","@type":"Researcher","foaf:name":[{"@value":"L. Schmitt"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993551785344","@type":"Researcher","foaf:name":[{"@value":"J. Speckman"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993551785473","@type":"Researcher","foaf:name":[{"@value":"J. Ansell"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09295305"},{"@type":"EISSN","@value":"1573742X"}],"prism:publicationName":[{"@value":"Journal of Thrombosis and Thrombolysis"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2003-06","prism:volume":"15","prism:number":"3","prism:startingPage":"213","prism:endingPage":"216"},"reviewed":"false","dc:rights":["https://www.springernature.com/gp/researchers/text-and-data-mining","https://www.springernature.com/gp/researchers/text-and-data-mining"],"url":[{"@id":"https://link.springer.com/content/pdf/10.1023/B:THRO.0000011377.78585.63.pdf"},{"@id":"https://link.springer.com/article/10.1023/B:THRO.0000011377.78585.63/fulltext.html"}],"createdAt":"2004-01-09","modifiedAt":"2025-08-08","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360565168096947456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205102226048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Anticoagulation Control Quality Affects the D-Dimer Levels of Atrial Fibrillation Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205106470016","@type":"Article","resourceType":"エディトリアル(editorial)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Predictors of International Normalized Ratio Variability in Patients With Atrial Fibrillation Under Warfarin Therapy"},{"@value":"Who Will Achieve Stable Anticoagulation Therapy With Warfarin?"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205224299008","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Risks and Benefits of Combined Use of Bucolome and Warfarin in Anticoagulation Therapy"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1023/b:thro.0000011377.78585.63"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-16-1217_references_DOI_Y78UHbfN4RCBHMdkuUOVOApq0SL"},{"@type":"CROSSREF","@value":"10.1536/ihj.51.399_references_DOI_Y78UHbfN4RCBHMdkuUOVOApq0SL"},{"@type":"CROSSREF","@value":"10.1111/bjh.14084_references_DOI_Y78UHbfN4RCBHMdkuUOVOApq0SL"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-11-0885_references_DOI_Y78UHbfN4RCBHMdkuUOVOApq0SL"}]}